Dear Mr. Tibbs: July 18th, 2010
The pre-formulations used for the development of HepC Herba™ had been tested against a murine retrovirus and were found to be active against Ecotropic Murine Leukemia Virus (EMLV) in vitro before they were tested active against HIV-1 exo vivo.
Please see the U.S. Patent 5,989,556, Example 4, Table 2 on page 23.
HepC Herba™ has also been found to help those who have chronic fatigue from chronic hepatitis C and mononucleosis from Epstein-Barr virus infection. Those who took HepC Herba™ generally have more energy after two weeks of taking the formulation three times a day orally like drinking a coffee.
Shie-Ming Hwang, Ph.D.